July 30th, 2004
Abstract:
If Nanosys, which is scheduled to go public next week, prices at the high end of its $15 to $17 a share range, it would debut with a market value of about $372 million. So it would be trading at nearly 125 times last year's sales! Is a company that warns in its prospectus that it has yet to develop any products and may not do so for several years, if ever, really worth buying now?
Source:
CNN
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||